Rapid NO Measures in Rat Nucleus Accumbens and Frontal Cortex Following Nasal Administration

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/185/1/19

Funding

  • Berolina Drug Development GmbH: $95,933.00